Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Multifunctional plasmonic nanostructures have enormous potential in the treatment of solid tumors; however, tracking particles with
drug cargo and triggering the release of the cargo in mapped tumors is still impossible. To overcome this challenge we have developed
an MRI and fluorescent active nanostructure nanomatryoshka. This new nanostructure with IR plasmonic signatures is composed of a 50
nm Au core surrounded by dye molecules and Gd (III)-DOTA chelate doped SiO2 inner-shell and an outer Au shell. The experimental result
demonstrates an enhanced T1 relaxation (r1~24 mM-1 s-1 at 4.7 T) compared to the clinical Gd (III)-DOTA chelating agents (r1~4 mM-1 s-1).
Further, this design preserves the fluorescence signal (65%) after 24 hours of exposure, leading to enhanced fluorescence photostability
(23x). This dual-imaging functionality nanosystem increases MRI sensitivity by concentrating Gd (III) ions into the Gd-NMs, reduces
the potential toxicity of Gd (III) ions and dye molecules by preventing their release in vivo through the outer Au shell protection, and the
terminal gold layer surface can then be functionalized to increase cellular uptake, circulation time, or thermal drug-release properties.